CA2558659C - Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie - Google Patents

Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie Download PDF

Info

Publication number: CA2558659C
Authority: CA; Canada
Prior art keywords: virus; recombinant; plasmid; vaccinia; fragment
Prior art date: 1991-03-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA002558659A

Other languages

English (en)

Other versions

CA2558659A1 (fr

Inventor

Enzo Paoletti

Marion E. Perkus

Jill Taylor

James Tartaglia

Elizabeth K. Norton

Michel Riviere

Charles De Taisne

Keith J. Limbach

Gerard P. Johnson

Steven E. Pincus

William I. Cox

Jean-Christophe F. Audonnet

Russell Robert Gettig

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Connaught Technology Corp

Original Assignee

Individual

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-03-07

Filing date

1992-03-09

Publication date

2008-06-03

1992-03-09 Application filed by Individual filed Critical Individual

1992-03-09 Priority to CA2621088A priority Critical patent/CA2621088C/fr

1992-03-09 Priority claimed from CA002105277A external-priority patent/CA2105277C/fr

1992-09-17 Publication of CA2558659A1 publication Critical patent/CA2558659A1/fr

2008-06-03 Application granted granted Critical

2008-06-03 Publication of CA2558659C publication Critical patent/CA2558659C/fr

2012-03-09 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

229960005486 vaccine Drugs 0.000 title claims abstract description 41
241000178270 Canarypox virus Species 0.000 title claims abstract description 23
241000700605 Viruses Species 0.000 claims abstract description 251
230000002238 attenuated effect Effects 0.000 claims abstract description 16
108090000623 proteins and genes Proteins 0.000 claims description 338
210000004027 cell Anatomy 0.000 claims description 318
241000700721 Hepatitis B virus Species 0.000 claims description 104
102000004169 proteins and genes Human genes 0.000 claims description 103
241000701093 Suid alphaherpesvirus 1 Species 0.000 claims description 86
241000725303 Human immunodeficiency virus Species 0.000 claims description 69
230000006798 recombination Effects 0.000 claims description 61
238000005215 recombination Methods 0.000 claims description 58
238000000338 in vitro Methods 0.000 claims description 53
241000701044 Human gammaherpesvirus 4 Species 0.000 claims description 52
241000710842 Japanese encephalitis virus Species 0.000 claims description 48
241000710772 Yellow fever virus Species 0.000 claims description 48
229940051021 yellow-fever virus Drugs 0.000 claims description 48
241001465754 Metazoa Species 0.000 claims description 41
229940023860 canarypox virus HIV vaccine Drugs 0.000 claims description 39
238000000034 method Methods 0.000 claims description 38
241000711404 Avian avulavirus 1 Species 0.000 claims description 19
230000028993 immune response Effects 0.000 claims description 19
241000711798 Rabies lyssavirus Species 0.000 claims description 11
238000000746 purification Methods 0.000 claims description 10
241000712079 Measles morbillivirus Species 0.000 claims description 9
241000700584 Simplexvirus Species 0.000 claims description 8
210000002950 fibroblast Anatomy 0.000 claims description 8
241000712461 unidentified influenza virus Species 0.000 claims description 8
230000000890 antigenic effect Effects 0.000 claims description 6
210000003837 chick embryo Anatomy 0.000 claims description 6
108091029865 Exogenous DNA Proteins 0.000 claims description 5
230000001939 inductive effect Effects 0.000 claims description 5
241000714165 Feline leukemia virus Species 0.000 claims description 4
241000701931 Canine parvovirus Species 0.000 claims description 3
241000193449 Clostridium tetani Species 0.000 claims description 3
241000230501 Equine herpesvirus sp. Species 0.000 claims description 3
241000283073 Equus caballus Species 0.000 claims description 3
241000701087 Felid alphaherpesvirus 1 Species 0.000 claims description 3
241000150562 Hantaan orthohantavirus Species 0.000 claims description 3
241000701024 Human betaherpesvirus 5 Species 0.000 claims description 3
241000711386 Mumps virus Species 0.000 claims description 3
241000713311 Simian immunodeficiency virus Species 0.000 claims description 3
241001529453 unidentified herpesvirus Species 0.000 claims description 3
229920001817 Agar Polymers 0.000 claims description 2
241000283690 Bos taurus Species 0.000 claims description 2
241000710780 Bovine viral diarrhea virus 1 Species 0.000 claims description 2
239000008272 agar Substances 0.000 claims description 2
241000725619 Dengue virus Species 0.000 claims 1
108700026244 Open Reading Frames Proteins 0.000 abstract description 68
239000013598 vector Substances 0.000 abstract description 64
230000006870 function Effects 0.000 abstract description 16
230000002068 genetic effect Effects 0.000 abstract description 15
230000001018 virulence Effects 0.000 abstract description 15
230000002779 inactivation Effects 0.000 abstract description 8
230000001965 increasing effect Effects 0.000 abstract description 6
230000007923 virulence factor Effects 0.000 abstract description 4
239000000304 virulence factor Substances 0.000 abstract description 4
239000013612 plasmid Substances 0.000 description 409
239000012634 fragment Substances 0.000 description 372
206010046865 Vaccinia virus infection Diseases 0.000 description 226
208000007089 vaccinia Diseases 0.000 description 226
241000700618 Vaccinia virus Species 0.000 description 216
239000002773 nucleotide Substances 0.000 description 153
125000003729 nucleotide group Chemical group 0.000 description 153
238000012217 deletion Methods 0.000 description 126
230000037430 deletion Effects 0.000 description 126
108091034117 Oligonucleotide Proteins 0.000 description 112
235000018102 proteins Nutrition 0.000 description 96
JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 94
241000699670 Mus sp. Species 0.000 description 83
238000011081 inoculation Methods 0.000 description 79
108020004414 DNA Proteins 0.000 description 77
230000014509 gene expression Effects 0.000 description 76
239000002299 complementary DNA Substances 0.000 description 62
239000000047 product Substances 0.000 description 59
238000003752 polymerase chain reaction Methods 0.000 description 58
238000010276 construction Methods 0.000 description 57
210000003501 vero cell Anatomy 0.000 description 55
101710154606 Hemagglutinin Proteins 0.000 description 51
101710093908 Outer capsid protein VP4 Proteins 0.000 description 51
101710135467 Outer capsid protein sigma-1 Proteins 0.000 description 51
101710176177 Protein A56 Proteins 0.000 description 51
238000010367 cloning Methods 0.000 description 49
238000003780 insertion Methods 0.000 description 49
230000037431 insertion Effects 0.000 description 48
108700004025 env Genes Proteins 0.000 description 46
101150030339 env gene Proteins 0.000 description 45
108090000288 Glycoproteins Proteins 0.000 description 44
102000003886 Glycoproteins Human genes 0.000 description 44
206010037742 Rabies Diseases 0.000 description 43
238000001114 immunoprecipitation Methods 0.000 description 41
230000000694 effects Effects 0.000 description 40
239000000185 hemagglutinin Substances 0.000 description 40
208000015181 infectious disease Diseases 0.000 description 39
241000588724 Escherichia coli Species 0.000 description 38
238000002474 experimental method Methods 0.000 description 38
230000000875 corresponding effect Effects 0.000 description 37
230000029087 digestion Effects 0.000 description 37
241000713772 Human immunodeficiency virus 1 Species 0.000 description 35
210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 34
239000000523 sample Substances 0.000 description 34
230000036961 partial effect Effects 0.000 description 32
210000004989 spleen cell Anatomy 0.000 description 32
150000001413 amino acids Chemical group 0.000 description 31
210000002966 serum Anatomy 0.000 description 31
108010017826 DNA Polymerase I Proteins 0.000 description 30
102000004594 DNA Polymerase I Human genes 0.000 description 30
241000283973 Oryctolagus cuniculus Species 0.000 description 30
239000002609 medium Substances 0.000 description 28
230000014616 translation Effects 0.000 description 28
101000686824 Enterobacteria phage N4 Virion DNA-directed RNA polymerase Proteins 0.000 description 27
101000644628 Escherichia phage Mu Tail fiber assembly protein U Proteins 0.000 description 27
108091028043 Nucleic acid sequence Proteins 0.000 description 27
238000013519 translation Methods 0.000 description 27
108020004440 Thymidine kinase Proteins 0.000 description 26
210000004899 c-terminal region Anatomy 0.000 description 26
241000701074 Human alphaherpesvirus 2 Species 0.000 description 25
238000004458 analytical method Methods 0.000 description 25
239000006166 lysate Substances 0.000 description 24
241000271566 Aves Species 0.000 description 23
108091081024 Start codon Proteins 0.000 description 23
235000001014 amino acid Nutrition 0.000 description 23
239000000872 buffer Substances 0.000 description 23
108091026890 Coding region Proteins 0.000 description 22
239000000427 antigen Substances 0.000 description 22
108091007433 antigens Proteins 0.000 description 22
102000036639 antigens Human genes 0.000 description 22
108010005774 beta-Galactosidase Proteins 0.000 description 22
230000003612 virological effect Effects 0.000 description 22
101150039660 HA gene Proteins 0.000 description 21
102000006601 Thymidine Kinase Human genes 0.000 description 21
238000012360 testing method Methods 0.000 description 21
241000894007 species Species 0.000 description 20
101150039990 B13R gene Proteins 0.000 description 19
241000700662 Fowlpox virus Species 0.000 description 19
230000004927 fusion Effects 0.000 description 19
238000002703 mutagenesis Methods 0.000 description 19
231100000350 mutagenesis Toxicity 0.000 description 19
108090000765 processed proteins & peptides Proteins 0.000 description 19
230000004044 response Effects 0.000 description 19
230000005030 transcription termination Effects 0.000 description 19
101150071286 SPI-2 gene Proteins 0.000 description 18
230000010076 replication Effects 0.000 description 18
102100026189 Beta-galactosidase Human genes 0.000 description 17
208000031886 HIV Infections Diseases 0.000 description 17
241000713340 Human immunodeficiency virus 2 Species 0.000 description 17
238000003556 assay Methods 0.000 description 17
238000006243 chemical reaction Methods 0.000 description 17
238000011144 upstream manufacturing Methods 0.000 description 17
108020004705 Codon Proteins 0.000 description 16
229920002684 Sepharose Polymers 0.000 description 16
238000002255 vaccination Methods 0.000 description 15
241000282693 Cercopithecidae Species 0.000 description 14
102000016928 DNA-directed DNA polymerase Human genes 0.000 description 14
108010014303 DNA-directed DNA polymerase Proteins 0.000 description 14
241000282326 Felis catus Species 0.000 description 14
201000005505 Measles Diseases 0.000 description 14
241000699666 Mus <mouse, genus> Species 0.000 description 14
238000007792 addition Methods 0.000 description 14
235000021186 dishes Nutrition 0.000 description 14
101150029683 gB gene Proteins 0.000 description 14
238000011534 incubation Methods 0.000 description 14
108020005038 Terminator Codon Proteins 0.000 description 13
238000009396 hybridization Methods 0.000 description 13
230000003053 immunization Effects 0.000 description 13
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 12
101100287475 Vaccinia virus (strain Western Reserve) VACWR034 gene Proteins 0.000 description 12
239000012531 culture fluid Substances 0.000 description 12
238000010166 immunofluorescence Methods 0.000 description 12
239000013615 primer Substances 0.000 description 12
230000001681 protective effect Effects 0.000 description 12
DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 12
241000282472 Canis lupus familiaris Species 0.000 description 11
241000287828 Gallus gallus Species 0.000 description 11
108010041388 Ribonucleotide Reductases Proteins 0.000 description 11
102000000505 Ribonucleotide Reductases Human genes 0.000 description 11
239000012911 assay medium Substances 0.000 description 11
235000013330 chicken meat Nutrition 0.000 description 11
230000002008 hemorrhagic effect Effects 0.000 description 11
210000001519 tissue Anatomy 0.000 description 11
230000035897 transcription Effects 0.000 description 11
238000013518 transcription Methods 0.000 description 11
OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 10
101710132601 Capsid protein Proteins 0.000 description 10
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 10
231100000111 LD50 Toxicity 0.000 description 10
238000012300 Sequence Analysis Methods 0.000 description 10
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
230000015572 biosynthetic process Effects 0.000 description 10
239000013553 cell monolayer Substances 0.000 description 10
230000000295 complement effect Effects 0.000 description 10
230000003013 cytotoxicity Effects 0.000 description 10
231100000135 cytotoxicity Toxicity 0.000 description 10
238000010790 dilution Methods 0.000 description 10
239000012895 dilution Substances 0.000 description 10
239000012091 fetal bovine serum Substances 0.000 description 10
239000000499 gel Substances 0.000 description 10
230000012010 growth Effects 0.000 description 10
238000002649 immunization Methods 0.000 description 10
YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 10
102000004196 processed proteins & peptides Human genes 0.000 description 10
238000002741 site-directed mutagenesis Methods 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 9
239000007983 Tris buffer Substances 0.000 description 9
230000005875 antibody response Effects 0.000 description 9
239000013256 coordination polymer Substances 0.000 description 9
LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 9
239000002054 inoculum Substances 0.000 description 9
239000000463 material Substances 0.000 description 9
HPNSFSBZBAHARI-RUDMXATFSA-N mycophenolic acid Chemical compound OC1=C(C\C=C(/C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-RUDMXATFSA-N 0.000 description 9
239000002953 phosphate buffered saline Substances 0.000 description 9
238000007920 subcutaneous administration Methods 0.000 description 9
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 9
108091003079 Bovine Serum Albumin Proteins 0.000 description 8
241000700198 Cavia Species 0.000 description 8
UHDGCWIWMRVCDJ-CCXZUQQUSA-N Cytarabine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O1 UHDGCWIWMRVCDJ-CCXZUQQUSA-N 0.000 description 8
230000004543 DNA replication Effects 0.000 description 8
101150096427 I3L gene Proteins 0.000 description 8
241000282553 Macaca Species 0.000 description 8
101100287474 Vaccinia virus (strain Copenhagen) K3L gene Proteins 0.000 description 8
108020005202 Viral DNA Proteins 0.000 description 8
238000009825 accumulation Methods 0.000 description 8
239000004202 carbamide Substances 0.000 description 8
229910052799 carbon Inorganic materials 0.000 description 8
201000003740 cowpox Diseases 0.000 description 8
230000005764 inhibitory process Effects 0.000 description 8
KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
HPNSFSBZBAHARI-UHFFFAOYSA-N micophenolic acid Natural products OC1=C(CC=C(C)CCC(O)=O)C(OC)=C(C)C2=C1C(=O)OC2 HPNSFSBZBAHARI-UHFFFAOYSA-N 0.000 description 8
229960000951 mycophenolic acid Drugs 0.000 description 8
230000003472 neutralizing effect Effects 0.000 description 8
239000002245 particle Substances 0.000 description 8
244000052769 pathogen Species 0.000 description 8
238000012809 post-inoculation Methods 0.000 description 8
239000002244 precipitate Substances 0.000 description 8
235000014748 Amaranthus tricolor Nutrition 0.000 description 7
238000002965 ELISA Methods 0.000 description 7
102100038132 Endogenous retrovirus group K member 6 Pro protein Human genes 0.000 description 7
101150034814 F gene Proteins 0.000 description 7
101150082239 G gene Proteins 0.000 description 7
101710139711 IkB-like protein Proteins 0.000 description 7
DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 7
102100032105 Transmembrane emp24 domain-containing protein 5 Human genes 0.000 description 7
239000011543 agarose gel Substances 0.000 description 7
239000013592 cell lysate Substances 0.000 description 7
239000006285 cell suspension Substances 0.000 description 7
230000001472 cytotoxic effect Effects 0.000 description 7
230000001506 immunosuppresive effect Effects 0.000 description 7
238000007918 intramuscular administration Methods 0.000 description 7
238000006386 neutralization reaction Methods 0.000 description 7
230000001717 pathogenic effect Effects 0.000 description 7
239000002243 precursor Substances 0.000 description 7
238000012545 processing Methods 0.000 description 7
101150023320 B16R gene Proteins 0.000 description 6
102000053602 DNA Human genes 0.000 description 6
108010076504 Protein Sorting Signals Proteins 0.000 description 6
101150003725 TK gene Proteins 0.000 description 6
108010046722 Thrombospondin 1 Proteins 0.000 description 6
231100000433 cytotoxic Toxicity 0.000 description 6
UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 6
239000012636 effector Substances 0.000 description 6
238000001962 electrophoresis Methods 0.000 description 6
101150002378 gC gene Proteins 0.000 description 6
101150055782 gH gene Proteins 0.000 description 6
210000005260 human cell Anatomy 0.000 description 6
230000002163 immunogen Effects 0.000 description 6
238000001727 in vivo Methods 0.000 description 6
238000007917 intracranial administration Methods 0.000 description 6
108700004029 pol Genes Proteins 0.000 description 6
229920001184 polypeptide Polymers 0.000 description 6
238000001556 precipitation Methods 0.000 description 6
238000011160 research Methods 0.000 description 6
210000000952 spleen Anatomy 0.000 description 6
238000010561 standard procedure Methods 0.000 description 6
230000000638 stimulation Effects 0.000 description 6
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 6
238000004448 titration Methods 0.000 description 6
230000002103 transcriptional effect Effects 0.000 description 6
102000002260 Alkaline Phosphatase Human genes 0.000 description 5
108020004774 Alkaline Phosphatase Proteins 0.000 description 5
101150019032 B29R gene Proteins 0.000 description 5
101150061732 M2L gene Proteins 0.000 description 5
241000282579 Pan Species 0.000 description 5
101800003344 Vaccinia growth factor Proteins 0.000 description 5
101100534084 Vaccinia virus (strain Copenhagen) B14R gene Proteins 0.000 description 5
101100004092 Vaccinia virus (strain Western Reserve) VACWR196 gene Proteins 0.000 description 5
229940098773 bovine serum albumin Drugs 0.000 description 5
239000001506 calcium phosphate Substances 0.000 description 5
229910000389 calcium phosphate Inorganic materials 0.000 description 5
235000011010 calcium phosphates Nutrition 0.000 description 5
210000000170 cell membrane Anatomy 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
230000008859 change Effects 0.000 description 5
239000003153 chemical reaction reagent Substances 0.000 description 5
238000003776 cleavage reaction Methods 0.000 description 5
108020001507 fusion proteins Proteins 0.000 description 5
101150036031 gD gene Proteins 0.000 description 5
238000002955 isolation Methods 0.000 description 5
231100000518 lethal Toxicity 0.000 description 5
230000001665 lethal effect Effects 0.000 description 5
239000012139 lysis buffer Substances 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
229930182817 methionine Natural products 0.000 description 5
125000001360 methionine group Chemical group N[C@@H](CCSC)C(=O)* 0.000 description 5
239000000203 mixture Substances 0.000 description 5
238000002360 preparation method Methods 0.000 description 5
238000003127 radioimmunoassay Methods 0.000 description 5
108091008146 restriction endonucleases Proteins 0.000 description 5
230000007017 scission Effects 0.000 description 5
230000028327 secretion Effects 0.000 description 5
239000011734 sodium Substances 0.000 description 5
239000011780 sodium chloride Substances 0.000 description 5
238000001179 sorption measurement Methods 0.000 description 5
239000006228 supernatant Substances 0.000 description 5
238000003786 synthesis reaction Methods 0.000 description 5
QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 5
229920000936 Agarose Polymers 0.000 description 4
241000700663 Avipoxvirus Species 0.000 description 4
101710172503 Chemokine-binding protein Proteins 0.000 description 4
241000700626 Cowpox virus Species 0.000 description 4
230000004544 DNA amplification Effects 0.000 description 4
RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
239000006145 Eagle's minimal essential medium Substances 0.000 description 4
101710121417 Envelope glycoprotein Proteins 0.000 description 4
101000708009 Homo sapiens Sentrin-specific protease 8 Proteins 0.000 description 4
102000014150 Interferons Human genes 0.000 description 4
108010050904 Interferons Proteins 0.000 description 4
239000000020 Nitrocellulose Substances 0.000 description 4
241001494479 Pecora Species 0.000 description 4
101710138270 PspA protein Proteins 0.000 description 4
241000282695 Saimiri Species 0.000 description 4
102100031407 Sentrin-specific protease 8 Human genes 0.000 description 4
238000000692 Student's t-test Methods 0.000 description 4
241000282898 Sus scrofa Species 0.000 description 4
238000010521 absorption reaction Methods 0.000 description 4
230000003321 amplification Effects 0.000 description 4
150000001540 azides Chemical class 0.000 description 4
230000008901 benefit Effects 0.000 description 4
210000004556 brain Anatomy 0.000 description 4
238000004113 cell culture Methods 0.000 description 4
238000011161 development Methods 0.000 description 4
201000010099 disease Diseases 0.000 description 4
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
230000005782 double-strand break Effects 0.000 description 4
102000037865 fusion proteins Human genes 0.000 description 4
230000036039 immunity Effects 0.000 description 4
230000000977 initiatory effect Effects 0.000 description 4
229940079322 interferon Drugs 0.000 description 4
210000004698 lymphocyte Anatomy 0.000 description 4
230000014759 maintenance of location Effects 0.000 description 4
239000003550 marker Substances 0.000 description 4
230000004048 modification Effects 0.000 description 4
238000012986 modification Methods 0.000 description 4
230000035772 mutation Effects 0.000 description 4
229920001220 nitrocellulos Polymers 0.000 description 4
238000003199 nucleic acid amplification method Methods 0.000 description 4
101150053109 p28 gene Proteins 0.000 description 4
239000013600 plasmid vector Substances 0.000 description 4
101150088264 pol gene Proteins 0.000 description 4
244000144977 poultry Species 0.000 description 4
235000013594 poultry meat Nutrition 0.000 description 4
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 4
230000000644 propagated effect Effects 0.000 description 4
229910052708 sodium Inorganic materials 0.000 description 4
230000002269 spontaneous effect Effects 0.000 description 4
230000004083 survival effect Effects 0.000 description 4
238000001890 transfection Methods 0.000 description 4
230000001052 transient effect Effects 0.000 description 4
230000029812 viral genome replication Effects 0.000 description 4
230000003442 weekly effect Effects 0.000 description 4
108010039627 Aprotinin Proteins 0.000 description 3
101150095960 B19R gene Proteins 0.000 description 3
241000282552 Chlorocebus aethiops Species 0.000 description 3
101100233978 Cowpox virus (strain GRI-90 / Grishak) KBTB2 gene Proteins 0.000 description 3
102000012410 DNA Ligases Human genes 0.000 description 3
108010061982 DNA Ligases Proteins 0.000 description 3
239000003155 DNA primer Substances 0.000 description 3
230000007023 DNA restriction-modification system Effects 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
108060002716 Exonuclease Proteins 0.000 description 3
208000000666 Fowlpox Diseases 0.000 description 3
108020005350 Initiator Codon Proteins 0.000 description 3
241000282560 Macaca mulatta Species 0.000 description 3
229930182555 Penicillin Natural products 0.000 description 3
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 3
108091005804 Peptidases Proteins 0.000 description 3
239000004365 Protease Substances 0.000 description 3
108020004682 Single-Stranded DNA Proteins 0.000 description 3
101710137302 Surface antigen S Proteins 0.000 description 3
230000024932 T cell mediated immunity Effects 0.000 description 3
101100004100 Vaccinia virus (strain Western Reserve) VACWR199 gene Proteins 0.000 description 3
101800001863 Variola growth factor Proteins 0.000 description 3
241000700647 Variola virus Species 0.000 description 3
230000002411 adverse Effects 0.000 description 3
229960004405 aprotinin Drugs 0.000 description 3
230000005540 biological transmission Effects 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000008280 blood Substances 0.000 description 3
238000009835 boiling Methods 0.000 description 3
238000012790 confirmation Methods 0.000 description 3
235000013601 eggs Nutrition 0.000 description 3
102000013165 exonuclease Human genes 0.000 description 3
238000000605 extraction Methods 0.000 description 3
238000010185 immunofluorescence analysis Methods 0.000 description 3
210000003000 inclusion body Anatomy 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 3
210000003292 kidney cell Anatomy 0.000 description 3
210000004072 lung Anatomy 0.000 description 3
239000007758 minimum essential medium Substances 0.000 description 3
150000007523 nucleic acids Chemical class 0.000 description 3
239000008188 pellet Substances 0.000 description 3
229940049954 penicillin Drugs 0.000 description 3
229920002401 polyacrylamide Polymers 0.000 description 3
230000002028 premature Effects 0.000 description 3
230000035755 proliferation Effects 0.000 description 3
235000019419 proteases Nutrition 0.000 description 3
108020003175 receptors Proteins 0.000 description 3
102000005962 receptors Human genes 0.000 description 3
229960001860 salicylate Drugs 0.000 description 3
238000007790 scraping Methods 0.000 description 3
230000035945 sensitivity Effects 0.000 description 3
239000002356 single layer Substances 0.000 description 3
238000009987 spinning Methods 0.000 description 3
238000010186 staining Methods 0.000 description 3
229960005322 streptomycin Drugs 0.000 description 3
239000000725 suspension Substances 0.000 description 3
239000003104 tissue culture media Substances 0.000 description 3
230000007704 transition Effects 0.000 description 3
241000700570 unidentified entomopoxvirus Species 0.000 description 3
108700026220 vif Genes Proteins 0.000 description 3
238000005406 washing Methods 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 2
JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
101710106459 29 kDa protein Proteins 0.000 description 2
108010068327 4-hydroxyphenylpyruvate dioxygenase Proteins 0.000 description 2
101150068622 ATI gene Proteins 0.000 description 2
101150020569 B3R gene Proteins 0.000 description 2
102100037084 C4b-binding protein alpha chain Human genes 0.000 description 2
101710159767 C4b-binding protein alpha chain Proteins 0.000 description 2
241000283707 Capra Species 0.000 description 2
241000700199 Cavia porcellus Species 0.000 description 2
108020003215 DNA Probes Proteins 0.000 description 2
239000003298 DNA probe Substances 0.000 description 2
238000001712 DNA sequencing Methods 0.000 description 2
208000001490 Dengue Diseases 0.000 description 2
206010012310 Dengue fever Diseases 0.000 description 2
101100450244 Dictyostelium discoideum hbx2 gene Proteins 0.000 description 2
101100364969 Dictyostelium discoideum scai gene Proteins 0.000 description 2
101150013191 E gene Proteins 0.000 description 2
102000005744 Glycoside Hydrolases Human genes 0.000 description 2
108010031186 Glycoside Hydrolases Proteins 0.000 description 2
239000007995 HEPES buffer Substances 0.000 description 2
102100031547 HLA class II histocompatibility antigen, DO alpha chain Human genes 0.000 description 2
208000032843 Hemorrhage Diseases 0.000 description 2
101000866278 Homo sapiens HLA class II histocompatibility antigen, DO alpha chain Proteins 0.000 description 2
108010091358 Hypoxanthine Phosphoribosyltransferase Proteins 0.000 description 2
101150076606 K3L gene Proteins 0.000 description 2
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
229930182816 L-glutamine Natural products 0.000 description 2
229910013465 LiC12 Inorganic materials 0.000 description 2
208000005647 Mumps Diseases 0.000 description 2
108010086093 Mung Bean Nuclease Proteins 0.000 description 2
101100364971 Mus musculus Scai gene Proteins 0.000 description 2
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
108010076039 Polyproteins Proteins 0.000 description 2
239000012083 RIPA buffer Substances 0.000 description 2
239000012980 RPMI-1640 medium Substances 0.000 description 2
101100277251 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) HEM12 gene Proteins 0.000 description 2
241000282696 Saimiri sciureus Species 0.000 description 2
206010039509 Scab Diseases 0.000 description 2
108091081021 Sense strand Proteins 0.000 description 2
101710172711 Structural protein Proteins 0.000 description 2
229930006000 Sucrose Natural products 0.000 description 2
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
108010008038 Synthetic Vaccines Proteins 0.000 description 2
210000001744 T-lymphocyte Anatomy 0.000 description 2
102100036034 Thrombospondin-1 Human genes 0.000 description 2
IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
101800001690 Transmembrane protein gp41 Proteins 0.000 description 2
101100540425 Vaccinia virus (strain Copenhagen) VGF gene Proteins 0.000 description 2
108010067390 Viral Proteins Proteins 0.000 description 2
230000001594 aberrant effect Effects 0.000 description 2
238000002835 absorbance Methods 0.000 description 2
230000006978 adaptation Effects 0.000 description 2
238000000137 annealing Methods 0.000 description 2
229940031567 attenuated vaccine Drugs 0.000 description 2
238000000376 autoradiography Methods 0.000 description 2
108010029566 avian influenza A virus hemagglutinin Proteins 0.000 description 2
108010058966 bacteriophage T7 induced DNA polymerase Proteins 0.000 description 2
RIIWUGSYXOBDMC-UHFFFAOYSA-N benzene-1,2-diamine;hydron;dichloride Chemical compound Cl.Cl.NC1=CC=CC=C1N RIIWUGSYXOBDMC-UHFFFAOYSA-N 0.000 description 2
IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 2
208000034158 bleeding Diseases 0.000 description 2
231100000319 bleeding Toxicity 0.000 description 2
230000000740 bleeding effect Effects 0.000 description 2
244000309466 calf Species 0.000 description 2
108091092356 cellular DNA Proteins 0.000 description 2
239000003795 chemical substances by application Substances 0.000 description 2
230000002860 competitive effect Effects 0.000 description 2
238000005520 cutting process Methods 0.000 description 2
230000001461 cytolytic effect Effects 0.000 description 2
230000000120 cytopathologic effect Effects 0.000 description 2
230000003247 decreasing effect Effects 0.000 description 2
208000025729 dengue disease Diseases 0.000 description 2
238000001514 detection method Methods 0.000 description 2
239000013024 dilution buffer Substances 0.000 description 2
210000002257 embryonic structure Anatomy 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000008029 eradication Effects 0.000 description 2
238000010195 expression analysis Methods 0.000 description 2
210000003722 extracellular fluid Anatomy 0.000 description 2
230000001605 fetal effect Effects 0.000 description 2
GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
108700004026 gag Genes Proteins 0.000 description 2
108091008053 gene clusters Proteins 0.000 description 2
239000001963 growth medium Substances 0.000 description 2
230000035931 haemagglutination Effects 0.000 description 2
238000010438 heat treatment Methods 0.000 description 2
210000002443 helper t lymphocyte Anatomy 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
210000000987 immune system Anatomy 0.000 description 2
230000005847 immunogenicity Effects 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000011065 in-situ storage Methods 0.000 description 2
230000006698 induction Effects 0.000 description 2
230000028709 inflammatory response Effects 0.000 description 2
239000003112 inhibitor Substances 0.000 description 2
239000007924 injection Substances 0.000 description 2
238000002347 injection Methods 0.000 description 2
238000007912 intraperitoneal administration Methods 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
239000012528 membrane Substances 0.000 description 2
208000010805 mumps infectious disease Diseases 0.000 description 2
108020004707 nucleic acids Proteins 0.000 description 2
102000039446 nucleic acids Human genes 0.000 description 2
230000037360 nucleotide metabolism Effects 0.000 description 2
229940124276 oligodeoxyribonucleotide Drugs 0.000 description 2
101150080184 p17 gene Proteins 0.000 description 2
230000026731 phosphorylation Effects 0.000 description 2
238000006366 phosphorylation reaction Methods 0.000 description 2
239000013641 positive control Substances 0.000 description 2
229940024231 poxvirus vaccine Drugs 0.000 description 2
235000021251 pulses Nutrition 0.000 description 2
229940049155 rabies serum Drugs 0.000 description 2
238000000163 radioactive labelling Methods 0.000 description 2
238000003156 radioimmunoprecipitation Methods 0.000 description 2
230000009257 reactivity Effects 0.000 description 2
229940124551 recombinant vaccine Drugs 0.000 description 2
230000002829 reductive effect Effects 0.000 description 2
230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 2
238000012216 screening Methods 0.000 description 2
239000003001 serine protease inhibitor Substances 0.000 description 2
230000000405 serological effect Effects 0.000 description 2
231100000444 skin lesion Toxicity 0.000 description 2
206010040882 skin lesion Diseases 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000005720 sucrose Substances 0.000 description 2
230000014621 translational initiation Effects 0.000 description 2
GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 2
210000000689 upper leg Anatomy 0.000 description 2
229940125575 vaccine candidate Drugs 0.000 description 2
238000012795 verification Methods 0.000 description 2
OSBLTNPMIGYQGY-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid;boric acid Chemical compound OB(O)O.OCC(N)(CO)CO.OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O OSBLTNPMIGYQGY-UHFFFAOYSA-N 0.000 description 1
NKDFYOWSKOHCCO-YPVLXUMRSA-N 20-hydroxyecdysone Chemical compound C1[C@@H](O)[C@@H](O)C[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@@](C)(O)[C@H](O)CCC(C)(O)C)CC[C@]33O)C)C3=CC(=O)[C@@H]21 NKDFYOWSKOHCCO-YPVLXUMRSA-N 0.000 description 1
238000010600 3H thymidine incorporation assay Methods 0.000 description 1
206010002091 Anaesthesia Diseases 0.000 description 1
102000006306 Antigen Receptors Human genes 0.000 description 1
108010083359 Antigen Receptors Proteins 0.000 description 1
101100121429 Arabidopsis thaliana GCL2 gene Proteins 0.000 description 1
101001073212 Arabidopsis thaliana Peroxidase 33 Proteins 0.000 description 1
MUXONAMCEUBVGA-DCAQKATOSA-N Arg-Arg-Gln Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCC(N)=O)C(O)=O MUXONAMCEUBVGA-DCAQKATOSA-N 0.000 description 1
238000011725 BALB/c mouse Methods 0.000 description 1
108700016947 Bos taurus structural-GP Proteins 0.000 description 1
101150111062 C gene Proteins 0.000 description 1
101100328879 Caenorhabditis elegans col-14 gene Proteins 0.000 description 1
108090000565 Capsid Proteins Proteins 0.000 description 1
101710205625 Capsid protein p24 Proteins 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
241000218645 Cedrus Species 0.000 description 1
102100023321 Ceruloplasmin Human genes 0.000 description 1
108091033380 Coding strand Proteins 0.000 description 1
108700010070 Codon Usage Proteins 0.000 description 1
102000006912 Complement C4b-Binding Protein Human genes 0.000 description 1
108010047548 Complement C4b-Binding Protein Proteins 0.000 description 1
101710184994 Complement control protein Proteins 0.000 description 1
108020004635 Complementary DNA Proteins 0.000 description 1
102100031673 Corneodesmosin Human genes 0.000 description 1
101710139375 Corneodesmosin Proteins 0.000 description 1
101100232885 Cowpox virus (strain Brighton Red) CPXV209 gene Proteins 0.000 description 1
108090000695 Cytokines Proteins 0.000 description 1
102000004127 Cytokines Human genes 0.000 description 1
230000006820 DNA synthesis Effects 0.000 description 1
229940122029 DNA synthesis inhibitor Drugs 0.000 description 1
102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
102100023933 Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial Human genes 0.000 description 1
BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
201000010374 Down Syndrome Diseases 0.000 description 1
108010067770 Endopeptidase K Proteins 0.000 description 1
101000621107 Enterobacteria phage N4 Probable portal protein Proteins 0.000 description 1
101710204837 Envelope small membrane protein Proteins 0.000 description 1
108010069621 Epstein-Barr virus EBV-associated membrane antigen Proteins 0.000 description 1
101001065501 Escherichia phage MS2 Lysis protein Proteins 0.000 description 1
241000701533 Escherichia virus T4 Species 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
102000008014 Eukaryotic Initiation Factor-2 Human genes 0.000 description 1
108010089791 Eukaryotic Initiation Factor-2 Proteins 0.000 description 1
206010015548 Euthanasia Diseases 0.000 description 1
241000710831 Flavivirus Species 0.000 description 1
101710177291 Gag polyprotein Proteins 0.000 description 1
206010069540 Generalised vaccinia Diseases 0.000 description 1
102100023303 Germ cell-less protein-like 1 Human genes 0.000 description 1
101000658545 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) Type I restriction enyme HindI endonuclease subunit Proteins 0.000 description 1
239000012981 Hank's balanced salt solution Substances 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
101000830085 Homo sapiens Germ cell-less protein-like 1 Proteins 0.000 description 1
101001123325 Homo sapiens Peroxisome proliferator-activated receptor gamma coactivator 1-beta Proteins 0.000 description 1
108010001336 Horseradish Peroxidase Proteins 0.000 description 1
108010048209 Human Immunodeficiency Virus Proteins Proteins 0.000 description 1
102000018251 Hypoxanthine Phosphoribosyltransferase Human genes 0.000 description 1
XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
238000012404 In vitro experiment Methods 0.000 description 1
108050006617 Interleukin-1 receptor Proteins 0.000 description 1
102000019223 Interleukin-1 receptor Human genes 0.000 description 1
102100024319 Intestinal-type alkaline phosphatase Human genes 0.000 description 1
101710184243 Intestinal-type alkaline phosphatase Proteins 0.000 description 1
108091092195 Intron Proteins 0.000 description 1
YQEZLKZALYSWHR-UHFFFAOYSA-N Ketamine Chemical compound C=1C=CC=C(Cl)C=1C1(NC)CCCCC1=O YQEZLKZALYSWHR-UHFFFAOYSA-N 0.000 description 1
238000012218 Kunkel's method Methods 0.000 description 1
239000012741 Laemmli sample buffer Substances 0.000 description 1
208000032420 Latent Infection Diseases 0.000 description 1
108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
206010024769 Local reaction Diseases 0.000 description 1
206010025323 Lymphomas Diseases 0.000 description 1
101710145006 Lysis protein Proteins 0.000 description 1
102000043129 MHC class I family Human genes 0.000 description 1
108091054437 MHC class I family Proteins 0.000 description 1
101710125418 Major capsid protein Proteins 0.000 description 1
101710085938 Matrix protein Proteins 0.000 description 1
108010090054 Membrane Glycoproteins Proteins 0.000 description 1
102000012750 Membrane Glycoproteins Human genes 0.000 description 1
102000018697 Membrane Proteins Human genes 0.000 description 1
108010052285 Membrane Proteins Proteins 0.000 description 1
101710127721 Membrane protein Proteins 0.000 description 1
241001529936 Murinae Species 0.000 description 1
241000699660 Mus musculus Species 0.000 description 1
101100006982 Mus musculus Ppcdc gene Proteins 0.000 description 1
101150033828 NS1 gene Proteins 0.000 description 1
206010028980 Neoplasm Diseases 0.000 description 1
101100190845 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pmp-1 gene Proteins 0.000 description 1
206010067482 No adverse event Diseases 0.000 description 1
101710195254 Non-structural glycoprotein Proteins 0.000 description 1
101800000512 Non-structural protein 1 Proteins 0.000 description 1
101800000941 Non-structural protein 1' Proteins 0.000 description 1
101710189818 Non-structural protein 2a Proteins 0.000 description 1
101710163270 Nuclease Proteins 0.000 description 1
238000012408 PCR amplification Methods 0.000 description 1
101150064860 PRM gene Proteins 0.000 description 1
102100028961 Peroxisome proliferator-activated receptor gamma coactivator 1-beta Human genes 0.000 description 1
241000286209 Phasianidae Species 0.000 description 1
101710177166 Phosphoprotein Proteins 0.000 description 1
108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 1
102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 1
229920001213 Polysorbate 20 Polymers 0.000 description 1
101710150336 Protein Rex Proteins 0.000 description 1
101900083372 Rabies virus Glycoprotein Proteins 0.000 description 1
108020004511 Recombinant DNA Proteins 0.000 description 1
108010038081 SIV(mac) proteinase Proteins 0.000 description 1
101150013541 SPI-3 gene Proteins 0.000 description 1
241000288960 Saguinus oedipus Species 0.000 description 1
101000980867 Schizosaccharomyces pombe (strain 972 / ATCC 24843) Curved DNA-binding protein Proteins 0.000 description 1
MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
241000287231 Serinus Species 0.000 description 1
241000287219 Serinus canaria Species 0.000 description 1
101000982319 Shallot virus X Uncharacterized ORF4 protein Proteins 0.000 description 1
206010040914 Skin reaction Diseases 0.000 description 1
101710149279 Small delta antigen Proteins 0.000 description 1
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 1
238000002105 Southern blotting Methods 0.000 description 1
241000282887 Suidae Species 0.000 description 1
101100234922 Swinepox virus (strain Kasza) LAP gene Proteins 0.000 description 1
108700005078 Synthetic Genes Proteins 0.000 description 1
239000008051 TBE buffer Substances 0.000 description 1
206010044688 Trisomy 21 Diseases 0.000 description 1
GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 1
206010046861 Vaccination complication Diseases 0.000 description 1
101100382200 Vaccinia virus (strain Ankara) MVA018L gene Proteins 0.000 description 1
101100268528 Vaccinia virus (strain Copenhagen) A26L gene Proteins 0.000 description 1
101100004091 Vaccinia virus (strain Copenhagen) B15R gene Proteins 0.000 description 1
101100316831 Vaccinia virus (strain Copenhagen) B18R gene Proteins 0.000 description 1
101100382201 Vaccinia virus (strain Copenhagen) C7L gene Proteins 0.000 description 1
101100382202 Vaccinia virus (strain Western Reserve) VACWR021 gene Proteins 0.000 description 1
101100268529 Vaccinia virus (strain Western Reserve) VACWR149 gene Proteins 0.000 description 1
101100340726 Vaccinia virus (strain Western Reserve) VACWR197 gene Proteins 0.000 description 1
101100004099 Vaccinia virus (strain Western Reserve) VACWR200 gene Proteins 0.000 description 1
241000700622 Vaccinia virus Copenhagen Species 0.000 description 1
101900209501 Vaccinia virus Thymidine kinase Proteins 0.000 description 1
206010058874 Viraemia Diseases 0.000 description 1
108700005077 Viral Genes Proteins 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000004075 alteration Effects 0.000 description 1
210000001691 amnion Anatomy 0.000 description 1
238000001949 anaesthesia Methods 0.000 description 1
230000037005 anaesthesia Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
230000000840 anti-viral effect Effects 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
108010068380 arginylarginine Proteins 0.000 description 1
230000004888 barrier function Effects 0.000 description 1
230000001851 biosynthetic effect Effects 0.000 description 1
230000023555 blood coagulation Effects 0.000 description 1
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
239000004327 boric acid Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
201000011510 cancer Diseases 0.000 description 1
150000001720 carbohydrates Chemical class 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
230000007910 cell fusion Effects 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
238000001516 cell proliferation assay Methods 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
238000012512 characterization method Methods 0.000 description 1
210000003711 chorioallantoic membrane Anatomy 0.000 description 1
239000003593 chromogenic compound Substances 0.000 description 1
230000000052 comparative effect Effects 0.000 description 1
230000024203 complement activation Effects 0.000 description 1
230000001010 compromised effect Effects 0.000 description 1
238000011109 contamination Methods 0.000 description 1
230000002596 correlated effect Effects 0.000 description 1
239000012228 culture supernatant Substances 0.000 description 1
230000009089 cytolysis Effects 0.000 description 1
210000000805 cytoplasm Anatomy 0.000 description 1
230000001086 cytosolic effect Effects 0.000 description 1
230000007402 cytotoxic response Effects 0.000 description 1
238000002784 cytotoxicity assay Methods 0.000 description 1
231100000263 cytotoxicity test Toxicity 0.000 description 1
108010011219 dUTP pyrophosphatase Proteins 0.000 description 1
230000002950 deficient Effects 0.000 description 1
229940009976 deoxycholate Drugs 0.000 description 1
230000010460 detection of virus Effects 0.000 description 1
239000003599 detergent Substances 0.000 description 1
238000010586 diagram Methods 0.000 description 1
239000005546 dideoxynucleotide Substances 0.000 description 1
230000003467 diminishing effect Effects 0.000 description 1
210000001840 diploid cell Anatomy 0.000 description 1
208000037771 disease arising from reactivation of latent virus Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
206010014599 encephalitis Diseases 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
229960005542 ethidium bromide Drugs 0.000 description 1
238000011156 evaluation Methods 0.000 description 1
108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
210000003414 extremity Anatomy 0.000 description 1
238000011049 filling Methods 0.000 description 1
210000003953 foreskin Anatomy 0.000 description 1
238000007710 freezing Methods 0.000 description 1
230000008014 freezing Effects 0.000 description 1
210000002288 golgi apparatus Anatomy 0.000 description 1
238000003306 harvesting Methods 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
231100000283 hepatitis Toxicity 0.000 description 1
230000009215 host defense mechanism Effects 0.000 description 1
230000008348 humoral response Effects 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000010324 immunological assay Methods 0.000 description 1
239000012133 immunoprecipitate Substances 0.000 description 1
230000001976 improved effect Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000013067 intermediate product Substances 0.000 description 1
239000007927 intramuscular injection Substances 0.000 description 1
238000010255 intramuscular injection Methods 0.000 description 1
239000007928 intraperitoneal injection Substances 0.000 description 1
238000011835 investigation Methods 0.000 description 1
229960003299 ketamine Drugs 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
238000002372 labelling Methods 0.000 description 1
230000003902 lesion Effects 0.000 description 1
231100000636 lethal dose Toxicity 0.000 description 1
231100000225 lethality Toxicity 0.000 description 1
239000007788 liquid Substances 0.000 description 1
229940124590 live attenuated vaccine Drugs 0.000 description 1
229940023012 live-attenuated vaccine Drugs 0.000 description 1
238000013507 mapping Methods 0.000 description 1
201000006512 mast cell neoplasm Diseases 0.000 description 1
208000006971 mastocytoma Diseases 0.000 description 1
239000011159 matrix material Substances 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
210000004379 membrane Anatomy 0.000 description 1
210000004779 membrane envelope Anatomy 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
230000002503 metabolic effect Effects 0.000 description 1
238000013508 migration Methods 0.000 description 1
230000005012 migration Effects 0.000 description 1
230000037230 mobility Effects 0.000 description 1
238000010369 molecular cloning Methods 0.000 description 1
239000000178 monomer Substances 0.000 description 1
238000010172 mouse model Methods 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
210000000822 natural killer cell Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000002276 neurotropic effect Effects 0.000 description 1
238000011580 nude mouse model Methods 0.000 description 1
JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 1
230000007918 pathogenicity Effects 0.000 description 1
229920003023 plastic Polymers 0.000 description 1
238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
230000001323 posttranslational effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000009696 proliferative response Effects 0.000 description 1
125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 description 1
238000001243 protein synthesis Methods 0.000 description 1
230000017854 proteolysis Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
229960003127 rabies vaccine Drugs 0.000 description 1
230000009467 reduction Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
230000003362 replicative effect Effects 0.000 description 1
230000001177 retroviral effect Effects 0.000 description 1
230000000630 rising effect Effects 0.000 description 1
238000003118 sandwich ELISA Methods 0.000 description 1
229940016590 sarkosyl Drugs 0.000 description 1
108700004121 sarkosyl Proteins 0.000 description 1
238000011896 sensitive detection Methods 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
238000009589 serological test Methods 0.000 description 1
231100000430 skin reaction Toxicity 0.000 description 1
230000035483 skin reaction Effects 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
KSAVQLQVUXSOCR-UHFFFAOYSA-M sodium lauroyl sarcosinate Chemical compound [Na+].CCCCCCCCCCCC(=O)N(C)CC([O-])=O KSAVQLQVUXSOCR-UHFFFAOYSA-M 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000000527 sonication Methods 0.000 description 1
210000000278 spinal cord Anatomy 0.000 description 1
230000003393 splenic effect Effects 0.000 description 1
238000006467 substitution reaction Methods 0.000 description 1
230000003319 supportive effect Effects 0.000 description 1
230000002459 sustained effect Effects 0.000 description 1
210000000966 temporal muscle Anatomy 0.000 description 1
238000010257 thawing Methods 0.000 description 1
101150118483 tmk gene Proteins 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
210000000427 trigeminal ganglion Anatomy 0.000 description 1
238000003211 trypan blue cell staining Methods 0.000 description 1
241001430294 unidentified retrovirus Species 0.000 description 1
210000003462 vein Anatomy 0.000 description 1
230000006648 viral gene expression Effects 0.000 description 1
230000009385 viral infection Effects 0.000 description 1
230000017613 viral reproduction Effects 0.000 description 1
239000013603 viral vector Substances 0.000 description 1
210000002845 virion Anatomy 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1

Landscapes

Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

CA002558659A 1991-03-07 1992-03-09 Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie Expired - Lifetime CA2558659C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA2621088A CA2621088C (fr)	1991-03-07	1992-03-09	Souche vaccinale a base de variole aviaire a manipulation genetique

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US66605691A	1991-03-07	1991-03-07
US666,056		1991-03-07
US71396791A	1991-06-11	1991-06-11
US713,967		1991-06-11
US84795192A	1992-03-06	1992-03-06
US847,951		1992-03-06
CA002105277A CA2105277C (fr)	1991-03-07	1992-03-09	Souche de virus de la vaccine genetiquement modifiee

Related Parent Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002105277A Division CA2105277C (fr)	1991-03-07	1992-03-09	Souche de virus de la vaccine genetiquement modifiee

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2621088A Division CA2621088C (fr)	1991-03-07	1992-03-09	Souche vaccinale a base de variole aviaire a manipulation genetique

Publications (2)

Publication Number	Publication Date
CA2558659A1 CA2558659A1 (fr)	1992-09-17
CA2558659C true CA2558659C (fr)	2008-06-03

Family

ID=37310264

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA002558659A Expired - Lifetime CA2558659C (fr)	1991-03-07	1992-03-09	Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie

Country Status (1)

Country	Link
CA (1)	CA2558659C (fr)

1992
- 1992-03-09 CA CA002558659A patent/CA2558659C/fr not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2558659A1 (fr)	1992-09-17

Legal Events

Date	Code	Title	Description
2006-09-19	EEER	Examination request
2012-03-09	MKEX	Expiry

Publication	Publication Date	Title
US5766599A (en)	1998-06-16	Trova fowl pox virus recombinants comprising heterologous inserts
US5863542A (en)	1999-01-26	Recombinant attenuated ALVAC canaryopox virus containing heterologous HIV or SIV inserts
JP3083839B2 (ja)	2000-09-04	ヘルペスウイルス組換えポックスウイルスワクチン
AU6160196A (en)	1996-12-24	Recombinant poxvirus - cytomegalovirus compositions and uses
WO1996040241A1 (fr)	1996-12-19	Compositions recombinantes et compositions combinees de virus de la rage et de la variole, et leurs utilisations
JP2007254489A (ja)	2007-10-04	Ｈｔｌｖ抗原を発現する組換え弱毒化ポックスウイルスを含有する免疫原性組成物
US5989561A (en)	1999-11-23	Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
CA2105277C (fr)	2006-12-12	Souche de virus de la vaccine genetiquement modifiee
WO1996039177A9 (fr)	1997-01-30	Compositions a base de poxvirus-calicivirus de recombinaison [virus de la maladie hemorragique du lapin (rhdv)] et leurs utilisations
CA2558659C (fr)	2008-06-03	Lignee de vaccins basee sur le virus de la variole du canari genetiquement modifie
CA2621088C (fr)	2010-11-02	Souche vaccinale a base de variole aviaire a manipulation genetique
EP1367128A1 (fr)	2003-12-03	Souche de vaccin mise au point par génie genétique
AU701599B2 (en)	1999-02-04	TROVAC fowlpox virus recombinants comprising heterologous inserts
AU747139B2 (en)	2002-05-09	Immunodeficiency recombinant poxvirus
AU2002300582B2 (en)	2005-12-15	Immunodeficiency Recombinant Poxvirus
AU2006201066A1 (en)	2006-03-30	Immunodeficiency recombinant poxvirus
AU2275595A (en)	1995-10-30	Immunodeficiency recombinant poxvirus
AU6247000A (en)	2000-12-14	Recombinant poxvirus-calicivirus (rabbit hemorrhagic disease virus (RHDV)) compositions and uses
AU5941300A (en)	2000-11-30	Recombinant poxvirus-cytomegalovirus, compositions and uses